异动解读03-31
Apellis Pharmaceuticals Inc.（APLS）今日盘前股价大幅上涨140.96%，引起了市场的广泛关注。
消息面上，生物制药巨头渤健公司（Biogen）已同意以约56亿美元现金收购Apellis制药公司，收购价格为每股41美元现金加上或有价值权（CVR）。此项战略收购旨在增强渤健在免疫学、罕见病以及肾脏疾病治疗领域的业务布局和产品组合。
市场分析认为，此次收购反映了大型制药企业通过并购具有创新疗法的小型生物技术公司来补充产品管线的战略趋势。受此明确的收购协议消息提振，Apellis公司股价在盘前交易时段应声飙升。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
